Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Evaluation of the Efficacy of BCG in Protecting Against Contact Challenge With Bovine Tuberculosis in Holstein-Friesian and Zebu Crossbred Calves in Ethiopia

View through CrossRef
Bovine tuberculosis (bTB) is prevalent in intensive dairy farms in Ethiopia. Vaccination could be an alternative control approach given the socio-economic challenges of a test-and-slaughter control strategy. The efficacy of the BCG was evaluated on 40 Holstein-Friesian (HF) and zebu crossbred calves recruited from single intradermal cervical comparative tuberculin (SICCT) test negative herds and randomly allocated into two groups. Twenty-two calves were vaccinated within 2 weeks of age, and 18 were kept as a control. Six weeks post-vaccination, the two groups were exposed and kept mixed with known SICCT test positive cows for 1 year. Immune responses were monitored by interferon gamma (IFN-γ) release assay (IGRA), SICCT test, and antibody assay. Vaccinated calves developed strong responses to the SICCT test at the sixth week post-vaccination, but did not respond to ESAT-6/CFP-10 peptide antigen-based IGRA. During the exposure, IFN-γ response to the specific peptide cocktail [F(2.44, 92.67) = 26.96; p < 0.001] and skin reaction to the specific proteins cocktail [F(1.7, 64.3); p < 0.001] increased progressively in both groups while their antibody responses were low. The prevalence of bTB was 88.9% (95% CI: 65.3–98.6) and 63.6% (95% CI: 40.7–83.8) in the control and vaccinated calves, respectively, based on Mycobacterium bovis isolation, giving a direct protective efficacy estimate of 28.4% (95% CI: −2.7 to 50.1). The proportion of vaccinated calves with lesion was 7.0% (34/484) against 11.4% (45/396) in control calves, representing a 38% (95% CI: 5.8–59.4) reduction of lesion prevalence. Besides, the severity of pathology was significantly lower (Mann–Whitney U-test, p < 0.05) in vaccinated (median score = 2.0, IQR = 0–4.75) than in control (median score = 5, IQR = 3.0–6.25) calves. Moreover, survival from M. bovis infection in vaccinated calves was significantly (log-rank test: χ2 = 6.749, p < 0.01) higher than that of the control calves. In conclusion, the efficacy of BCG was low, but the reduced frequency and severity of lesion in vaccinated calves could suggest its potential role in containing onward transmission.
Title: Evaluation of the Efficacy of BCG in Protecting Against Contact Challenge With Bovine Tuberculosis in Holstein-Friesian and Zebu Crossbred Calves in Ethiopia
Description:
Bovine tuberculosis (bTB) is prevalent in intensive dairy farms in Ethiopia.
Vaccination could be an alternative control approach given the socio-economic challenges of a test-and-slaughter control strategy.
The efficacy of the BCG was evaluated on 40 Holstein-Friesian (HF) and zebu crossbred calves recruited from single intradermal cervical comparative tuberculin (SICCT) test negative herds and randomly allocated into two groups.
Twenty-two calves were vaccinated within 2 weeks of age, and 18 were kept as a control.
Six weeks post-vaccination, the two groups were exposed and kept mixed with known SICCT test positive cows for 1 year.
Immune responses were monitored by interferon gamma (IFN-γ) release assay (IGRA), SICCT test, and antibody assay.
Vaccinated calves developed strong responses to the SICCT test at the sixth week post-vaccination, but did not respond to ESAT-6/CFP-10 peptide antigen-based IGRA.
During the exposure, IFN-γ response to the specific peptide cocktail [F(2.
44, 92.
67) = 26.
96; p < 0.
001] and skin reaction to the specific proteins cocktail [F(1.
7, 64.
3); p < 0.
001] increased progressively in both groups while their antibody responses were low.
The prevalence of bTB was 88.
9% (95% CI: 65.
3–98.
6) and 63.
6% (95% CI: 40.
7–83.
8) in the control and vaccinated calves, respectively, based on Mycobacterium bovis isolation, giving a direct protective efficacy estimate of 28.
4% (95% CI: −2.
7 to 50.
1).
The proportion of vaccinated calves with lesion was 7.
0% (34/484) against 11.
4% (45/396) in control calves, representing a 38% (95% CI: 5.
8–59.
4) reduction of lesion prevalence.
Besides, the severity of pathology was significantly lower (Mann–Whitney U-test, p < 0.
05) in vaccinated (median score = 2.
0, IQR = 0–4.
75) than in control (median score = 5, IQR = 3.
0–6.
25) calves.
Moreover, survival from M.
bovis infection in vaccinated calves was significantly (log-rank test: χ2 = 6.
749, p < 0.
01) higher than that of the control calves.
In conclusion, the efficacy of BCG was low, but the reduced frequency and severity of lesion in vaccinated calves could suggest its potential role in containing onward transmission.

Related Results

Effect of a once-daily suckling program on gastrointestinal parasitism in Angus cows and calves
Effect of a once-daily suckling program on gastrointestinal parasitism in Angus cows and calves
SUMMARY Over a 2-year period involving a total of 168 Angus cows and their calves, 2 studies were conducted to evaluate the effect of once-daily suckling on cow reproduction, calf ...
Performance of calves in dry season feedlot according to genetic group and sex
Performance of calves in dry season feedlot according to genetic group and sex
Abstract The aim of this study was to evaluate the feedlot strategy for beef calves as an alternative during the dry season, as well as differences in the performance betwe...
Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring
Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring
ABSTRACT The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG's...
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
Abstract The only licensed tuberculosis (TB) vaccine, Bacillus Calmette Guerin (BCG), fails to reliably protect adolescents and adults from pulmonary TB, resultin...
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
Abstract The only licensed tuberculosis (TB) vaccine, Bacillus Calmette Guerin (BCG), fails to reliably protect adolescents and adults from pulmonary TB, resulting in appro...

Back to Top